The patient and device codes were coded by the manufacturer.(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.There was no reported device malfunction and the product was not returned as the stent remains in the anatomy.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of thrombosis and restenosis are listed in the supera instructions for use as known potential patient effects.Based on the case information and related record review, a conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined and there is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that on (b)(6) 2017, the patient underwent a stenting procedure, with implantation of a 6.5 x 150 mm supera stent in the popliteal artery.On (b)(6) 2018, the patient presented with thrombus and restenosis in the implanted supera stent.Thrombectomy, angioplasty and implantation of an additional stent were performed.The patient remained in stable condition post procedure.No additional information was provided.
|